- Filed
- May 7, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2026 · May 4, 2026 | 62.79M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2026 | 58.63M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2026 | 49.57M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2025 | 41.36M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2025 | 40.21M sh |
| Capex | Q3 2026 · Mar 31, 2026 | $1.84M |
| Capex | Q3 2026 · Mar 31, 2025 | $580.73K |
| Operating Cash Flow | Q3 2026 · Mar 31, 2026 | −$5.12M |
| Operating Cash Flow | Q3 2026 · Mar 31, 2025 | −$5.68M |
| Cash And Equivalents | Q3 2026 · Mar 31, 2026 | $55.24M |
| Cash And Equivalents | Q3 2026 · Jun 30, 2025 | $4.88M |
| Stockholders Equity | Q3 2026 · Mar 31, 2026 | $89.09M |
| Stockholders Equity | Q3 2026 · Dec 31, 2025 | $77.94M |
| Stockholders Equity | Q3 2026 · Sep 30, 2025 | $21.44M |
| Stockholders Equity | Q3 2026 · Jun 30, 2025 | $15.64M |
| Stockholders Equity | Q3 2026 · Mar 31, 2025 | $15.72M |
| Stockholders Equity | Q3 2026 · Dec 31, 2024 | $26.7M |
| Stockholders Equity | Q3 2026 · Sep 30, 2024 | $29.44M |
| Stockholders Equity | Q3 2026 · Jun 30, 2024 | $30.2M |
| Current Liabilities | Q3 2026 · Mar 31, 2026 | $21.53M |
| Current Liabilities | Q3 2026 · Jun 30, 2025 | $17.1M |
| Total Liabilities | Q3 2026 · Mar 31, 2026 | $31.38M |
| Total Liabilities | Q3 2026 · Jun 30, 2025 | $31.63M |
| Current Assets | Q3 2026 · Mar 31, 2026 | $83M |
| Current Assets | Q3 2026 · Jun 30, 2025 | $28.37M |
| Total Assets | Q3 2026 · Mar 31, 2026 | $144.27M |
| Total Assets | Q3 2026 · Jun 30, 2025 | $81.51M |
| Eps Diluted | Q3 2026 · Mar 31, 2026 | −$0.07 |
| Eps Diluted | Q3 2026 · Mar 31, 2026 | −$0.33 |
| Eps Diluted restated | Q3 2026 · Mar 31, 2025 | −$0.09 |
| Eps Diluted restated | Q3 2026 · Mar 31, 2025 | −$0.19 |
| Eps Basic | Q3 2026 · Mar 31, 2026 | −$0.07 |
| Eps Basic | Q3 2026 · Mar 31, 2026 | −$0.33 |
| Eps Basic restated | Q3 2026 · Mar 31, 2025 | −$0.09 |
| Eps Basic restated | Q3 2026 · Mar 31, 2025 | −$0.19 |
| Sga Expense | Q3 2026 · Mar 31, 2026 | $6.3M |
| Sga Expense | Q3 2026 · Mar 31, 2026 | $16.54M |
| Sga Expense | Q3 2026 · Mar 31, 2025 | $4.45M |
| Sga Expense | Q3 2026 · Mar 31, 2025 | $11.08M |
| Rd Expense | Q3 2026 · Mar 31, 2026 | $1.04M |
| Rd Expense | Q3 2026 · Mar 31, 2026 | $2.66M |
| Rd Expense | Q3 2026 · Mar 31, 2025 | $757.94K |
| Rd Expense | Q3 2026 · Mar 31, 2025 | $2M |
| Net Income | Q3 2026 · Mar 31, 2026 | −$4.11M |
| Net Income | Q3 2026 · Mar 31, 2026 | −$16.4M |
| Net Income | Q3 2026 · Dec 31, 2025 | −$9.41M |
| Net Income | Q3 2026 · Sep 30, 2025 | −$2.89M |
| Net Income | Q3 2026 · Mar 31, 2025 | −$3.58M |
| Net Income | Q3 2026 · Mar 31, 2025 | −$7.82M |
| Net Income | Q3 2026 · Dec 31, 2024 | −$2.61M |
| Net Income | Q3 2026 · Sep 30, 2024 | −$1.62M |
| Operating Income | Q3 2026 · Mar 31, 2026 | −$4.25M |
| Operating Income | Q3 2026 · Mar 31, 2026 | −$15.36M |
| Operating Income restated | Q3 2026 · Mar 31, 2025 | −$3.45M |
| Operating Income restated | Q3 2026 · Mar 31, 2025 | −$7.31M |
| Gross Profit | Q3 2026 · Mar 31, 2026 | $6.96M |
| Gross Profit | Q3 2026 · Mar 31, 2026 | $17.46M |
| Gross Profit | Q3 2026 · Mar 31, 2025 | $2.66M |
| Gross Profit | Q3 2026 · Mar 31, 2025 | $7.44M |